🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
162.64
+0.54 (0.33%)
At close: Nov 20, 2026, 4:00 PM EST
162.83
+0.19 (0.12%)
After-hours: Nov 20, 2026, 7:30 PM EST

Nutex Health Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Nutex Health stock has a consensus rating of "Strong Buy" and an average price target of $313.67. The average 1-year stock price forecast is 92.86% higher than the current stock price, while the lowest is $250 (+53.71%) and the highest is $357 (+119.50%).

Price Target: $313.67 (+92.86%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$250$313.67$319.5$357
Change+53.71%+92.86%+96.45%+119.50%

Analyst Ratings

The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Aug '26Sep '26Oct '26Nov '26
Strong Buy244455
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total355566

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Reiterates
$250
BuyReiterates$250+53.71%Nov 10, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$325 → $357
BuyMaintains$325 → $357+119.50%Nov 9, 2026
Lake Street
Lake Street
Buy
Maintains
$310 → $333
BuyMaintains$310 → $333+104.75%Nov 9, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Initiates
$336
BuyInitiates$336+106.59%Oct 26, 2026
Freedom Capital Markets
Freedom Capital Markets
Buy
Maintains
$280 → $306
BuyMaintains$280 → $306+88.15%Sep 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
869.99M
from 875.26M
Decreased by -0.60%
Revenue Next Year
964.79M
from 869.99M
Increased by 10.90%
EPS This Year
19.59
EPS Next Year
20.33
from 19.59
Increased by 3.78%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
331.53M219.29M247.65M479.95M875.26M869.99M
Revenue Growth
20.98%-33.85%12.93%93.80%82.37%-0.60%
Gross Profit
186.94M28.55M57.87M220.83M471.31M440.43M
Gross Margin
56.39%13.02%23.37%46.01%53.85%50.63%
Operating Income
173.82M-4.58M-1.29M137.78M392.63M362.23M
Net Income
132.59M-424.78M-45.79M52.10M70.79M191.74M
EPS
-----19.59
Forward PE
---53.719.418.30
Free Cash Flow
-----8.50M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High874.2M
Avg870.0M
Low864.9M

Revenue Growth

Revenue Growth202620272028
High
-0.1%
Avg
-0.6%
Low
-1.2%

EPS Forecast

EPS202620272028
High19.59
Avg19.59
Low19.59

EPS Growth

EPS Growth20272028
High
3.8%
Avg
3.8%
Low
3.8%